BioCatalyst

Cebranopadol 400 ug — catalyst calendar

1 verified catalyst event(s) referencing Cebranopadol 400 ug, each linked to its official source. Verified as of 2026-09-29.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01 (month)
in 3mo
ESTIMATED
 READOUT
An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Ac
Phase 3 · Pain
 Adneuris Therapeutics, Inc. Cebranopadol 400 ug ClinicalTrials.gov ↗
✓ Source-checked 2026-09-29
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.